Sales 2024 * | 46.36B 49.64B | Sales 2025 * | 49.73B 53.25B | Capitalization | 111B 119B |
---|---|---|---|---|---|
Net income 2024 * | 7.34B 7.87B | Net income 2025 * | 8.62B 9.23B | EV / Sales 2024 * | 2.54 x |
Net Debt 2024 * | 6.89B 7.38B | Net Debt 2025 * | 2.7B 2.89B | EV / Sales 2025 * | 2.29 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
12.9
x | Employees | - |
Yield 2024 * |
4.3% | Yield 2025 * |
4.65% | Free-Float | 87.01% |
Latest transcript on Sanofi SA
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 19-08-31 |
Madeleine Roach
COO | Chief Operating Officer | 39 | 21-12-31 |
Chief Tech/Sci/R&D Officer | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 70 | 14-04-30 |
Gilles Schnepp
BRD | Director/Board Member | 64 | 20-05-21 |
Rachel Duan
BRD | Director/Board Member | 52 | 20-04-27 |
1st Jan change | Capi. | |
---|---|---|
+27.92% | 672B | |
+27.68% | 570B | |
-4.59% | 360B | |
+16.38% | 321B | |
+9.39% | 300B | |
+6.30% | 217B | |
+4.80% | 199B | |
-6.05% | 204B | |
-8.58% | 149B |